[PHARMA] YoY TTM Result on 30-Jun-2024 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Jun-2024 [#2]
Profit Trend
QoQ- 1.54%
YoY- 91.51%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 3,478,508 3,516,589 4,567,669 3,230,009 2,898,216 2,572,302 2,388,351 6.46%
PBT -35,980 -607,271 265,267 44,355 -189,383 72,267 75,814 -
Tax -15,121 -22,459 -100,008 -13,392 43,048 -23,482 -26,481 -8.90%
NP -51,101 -629,730 165,259 30,963 -146,335 48,785 49,333 -
-
NP to SH -53,617 -631,164 163,766 31,951 -145,739 48,386 48,260 -
-
Tax Rate - - 37.70% 30.19% - 32.49% 34.93% -
Total Cost 3,529,609 4,146,319 4,402,410 3,199,046 3,044,551 2,523,517 2,339,018 7.09%
-
Net Worth -272,968 -137,571 406,087 357,275 357,891 518,564 519,642 -
Dividend
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Div - 7,859 108,678 36,634 22,204 40,348 51,929 -
Div Payout % - 0.00% 66.36% 114.66% 0.00% 83.39% 107.60% -
Equity
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Net Worth -272,968 -137,571 406,087 357,275 357,891 518,564 519,642 -
NOSH 1,441,229 1,310,208 1,309,126 261,991 261,705 261,229 259,821 33.01%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -1.47% -17.91% 3.62% 0.96% -5.05% 1.90% 2.07% -
ROE 0.00% 0.00% 40.33% 8.94% -40.72% 9.33% 9.29% -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 241.36 268.40 348.69 246.81 1,109.43 987.13 919.23 -19.96%
EPS -3.72 -48.17 12.50 2.44 -55.79 18.57 18.57 -
DPS 0.00 0.60 8.30 2.80 8.50 15.50 20.00 -
NAPS -0.1894 -0.105 0.31 0.273 1.37 1.99 2.00 -
Adjusted Per Share Value based on latest NOSH - 1,441,229
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 241.36 244.00 316.93 224.11 201.09 178.48 165.72 6.46%
EPS -3.72 -43.79 11.36 2.22 -10.11 3.36 3.35 -
DPS 0.00 0.55 7.54 2.54 1.54 2.80 3.60 -
NAPS -0.1894 -0.0955 0.2818 0.2479 0.2483 0.3598 0.3606 -
Price Multiplier on Financial Quarter End Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 28/06/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 -
Price 0.37 0.37 0.595 5.29 2.22 2.84 2.88 -
P/RPS 0.15 0.14 0.17 2.14 0.20 0.29 0.31 -11.38%
P/EPS -9.95 -0.77 4.76 216.68 -3.98 15.29 15.51 -
EY -10.05 -130.20 21.01 0.46 -25.13 6.54 6.45 -
DY 0.00 1.62 13.95 0.53 3.83 5.46 6.94 -
P/NAPS 0.00 0.00 1.92 19.38 1.62 1.43 1.44 -
Price Multiplier on Announcement Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 21/08/24 11/08/23 19/08/22 20/08/21 19/08/20 23/08/19 17/08/18 -
Price 0.43 0.42 0.595 0.925 4.42 2.66 3.11 -
P/RPS 0.18 0.16 0.17 0.37 0.40 0.27 0.34 -10.04%
P/EPS -11.56 -0.87 4.76 37.89 -7.92 14.33 16.74 -
EY -8.65 -114.70 21.01 2.64 -12.62 6.98 5.97 -
DY 0.00 1.43 13.95 3.03 1.92 5.83 6.43 -
P/NAPS 0.00 0.00 1.92 3.39 3.23 1.34 1.56 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment